TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CRVS

Corvus Pharmaceuticals Inc

Healthcare · Biotechnology

11.60$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CRVS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.62 -0.56 -1.81 -2.26 -1.49 -1.27 -1.18 -0.88 -0.58 -0.50 -0.42 -0.41
0.87 0.01 0.04 0.04 0.03 0.03 0.02 0.01 0.01 0.00 0.00 0.00
– 0.02 0.25 0.30 0.26 0.25 0.19 0.10 0.06 0.04 0.05 0.07
105.87 0.88 0.29 0.29 0.26 0.25 -1.06 0.22 – – – –
0.05 0.09 0.22 0.13 -0.05 0.06 0.06 -0.08 0.03 -0.07 -0.03 0.04
10.26 0.09 0.14 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00
-540.48 -4.51 -2.76 4.14 -1.10 0.11 1.52 0.52 -0.50 0.32 -0.45 -0.10
– – 0.00 0.00 – – – – – – – –
0.01 4.69 4.63 0.07 2.37 0.00 0.04 – – – – –
80.81 4.65 4.63 0.07 2.37 0.00 0.04 1.49 0.00 0.16 0.80 0.46
80.19 -0.41 0.06 1.96 -0.21 -1.16 0.38 1.12 -1.08 -0.01 -0.06 -0.05
-0.62 -0.64 -1.95 -2.27 -1.50 -1.27 -1.18 -0.88 -0.59 -0.50 -0.42 -0.41

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?